Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆

Auteurs

N. Gaspar, Q. Campbell-Hewson, S. Gallego Melcon, F. Locatelli, R. Venkatramani, S. Hecker-Nolting, M. Gambart, F. Bautista, E. Thebaud, I. Aerts, B. Morland, C. Rossig, A. Canete Nieto, A. Longhi, C. Lervat, N. Entz-Werle, S.J. Strauss, P. Marec-Berard, C.E. Okpara, C. He, L. Dutta, M. Casanova